Medical professionals around the world use BinaxNOW^® rapid in vitro diagnostic tests to identify a variety of infectious diseases at the point of care. Our technologies detect bacteria and viruses causing upper and lower respiratory tract infections, including Legionnaires’ disease, pneumonia, RSV and influenza, as well as pathogens causing filariasis and malaria.

Rapid and accurate test results provide the foundation for pathogen-specific diagnosis, facilitating optimal patient management and infection control practices.

The post ABBOTT NOW appeared first on I.M. Κυριακίδης AE.

Transforming near-patient testing

ID NOW™ is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique  isothermal nucleic acid amplification technology provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.

For more information follow the link :

https://www.globalpointofcare.abbott/en/product-details/id-now.html

The post ID NOW™ appeared first on I.M. Κυριακίδης AE.